| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.13B | 8.83B | 10.98B | 12.58B | 14.39B | 9.80B |
| Gross Profit | 4.29B | 2.52B | 3.30B | 4.07B | 4.21B | 3.48B |
| EBITDA | 2.44B | 885.71M | 1.62B | 2.22B | 2.50B | 2.03B |
| Net Income | 5.41B | 554.11M | 1.14B | 5.26B | 4.27B | 1.49B |
Balance Sheet | ||||||
| Total Assets | 26.45B | 22.57B | 22.38B | 27.75B | 28.19B | 24.56B |
| Cash, Cash Equivalents and Short-Term Investments | 9.20B | 7.00B | 6.22B | 9.04B | 8.99B | 5.90B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 4.75B | 2.26B | 2.32B | 4.97B | 7.32B | 6.15B |
| Stockholders Equity | 21.70B | 20.31B | 20.06B | 22.78B | 20.87B | 18.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.37B | -1.10B | -3.38B | 197.40M | -351.44M |
| Operating Cash Flow | 0.00 | 2.41B | -522.70M | -2.35B | 454.28M | -323.02M |
| Investing Cash Flow | 0.00 | -40.72M | -516.59M | 3.94B | 3.31B | -21.08M |
| Financing Cash Flow | 0.00 | -1.49B | -1.87B | -1.54B | -565.80M | -502.64M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥15.78B | 28.69 | ― | 0.86% | -11.37% | 10.31% | |
74 Outperform | ¥59.65B | 14.94 | ― | 2.65% | -10.26% | -21.62% | |
73 Outperform | ¥12.22B | 5.95 | ― | 1.65% | 11.90% | 45.30% | |
68 Neutral | ¥19.52B | 28.21 | ― | 2.91% | -19.58% | -50.54% | |
68 Neutral | ¥10.04B | 10.67 | ― | 2.47% | 29.24% | 96.17% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
52 Neutral | ¥3.87B | 212.04 | ― | ― | 11.27% | 87.81% |